Premium Nahrungsergänzungsmittel | artgerecht

S-Adenosylhomocysteine (SAH) – Function and Significance

S-Adenosylhomocysteine (SAH) is a natural metabolic byproduct formed during the methylation cycle. It serves as a key biomarker for cellular methylation capacity and cardiovascular health.

Regular tips about health Regular tips about health

Things worth knowing about "S-Adenosylhomocysteine"

S-Adenosylhomocysteine (SAH) is a natural metabolic byproduct formed during the methylation cycle. It serves as a key biomarker for cellular methylation capacity and cardiovascular health.

What is S-Adenosylhomocysteine?

S-Adenosylhomocysteine (SAH), also abbreviated as AdoHcy, is a naturally occurring biochemical compound found in every cell of the human body. It is produced as the direct metabolic byproduct of S-adenosylmethionine (SAM), the primary methyl group donor in human metabolism. SAH plays a central role in the one-carbon metabolism pathway and is closely linked to homocysteine metabolism.

Formation and Metabolism

Within the methylation cycle, SAM donates a methyl group to various substrates including DNA, RNA, proteins, and lipids. In doing so, SAM is converted into SAH. SAH is subsequently cleaved by the enzyme S-adenosylhomocysteine hydrolase (SAHH) into homocysteine and adenosine. This reaction is reversible -- under physiological conditions, the equilibrium favors SAH synthesis when homocysteine is not rapidly metabolized.

SAM donates a methyl group and is converted to SAH.
SAH is cleaved by SAHH into homocysteine and adenosine.
Homocysteine is either remethylated back to methionine or further processed via the transsulfuration pathway.

Biological Significance

SAH is a potent inhibitor of numerous methyltransferases -- enzymes responsible for transferring methyl groups to other molecules. An increase in SAH levels therefore directly inhibits important methylation processes in the body, including:

DNA methylation (epigenetic regulation)
Protein methylation (e.g., histone modification)
Phospholipid methylation (membrane function)
Neurotransmitter synthesis

Since the ratio of SAM to SAH (the SAM/SAH ratio or methylation index) reflects the overall methylation status of a cell, SAH is considered an important biomarker for cellular methylation capacity.

Clinical Relevance

Elevated SAH levels in the blood have been associated with various medical conditions:

Cardiovascular disease: SAH is considered an independent risk factor for atherosclerosis and coronary artery disease -- potentially even more informative than homocysteine alone.
Chronic kidney disease: Since the kidneys play a major role in SAH clearance, impaired kidney function frequently leads to elevated SAH levels.
Neurological disorders: Altered SAH levels have been observed in neurodegenerative conditions such as Alzheimer disease and Parkinson disease.
Liver disease: The liver is the primary organ of methylation metabolism; liver conditions can significantly disrupt SAH metabolism.
Diabetes mellitus: Studies have shown altered SAM/SAH ratios in type 2 diabetes.

Diagnosis and Measurement

SAH can be measured in blood plasma or whole blood, typically using high-performance liquid chromatography (HPLC) or liquid chromatography-tandem mass spectrometry (LC-MS/MS). Measuring SAH together with SAM allows calculation of the SAM/SAH ratio, which serves as an indicator of methylation capacity. Reference ranges vary by laboratory and method; elevated values may indicate impaired methylation function.

Factors Influencing SAH Levels

Various factors can affect SAH levels in the body:

Diet: Deficiencies in folate, vitamin B12, vitamin B6, and riboflavin impair homocysteine and SAH metabolism.
Kidney function: Reduced kidney function leads to elevated SAH levels.
Medications: Certain drugs such as methotrexate or antiviral agents can interfere with SAH metabolism.
Genetic factors: Polymorphisms in genes such as MTHFR or SAHH can alter SAH regulation.
Oxidative stress: Chronic oxidative stress can disrupt methylation metabolism.

Therapeutic Approaches

Actively lowering elevated SAH levels is not yet an established standard therapeutic target; however, the following measures can support the methylation cycle:

Adequate intake of folate (vitamin B9), vitamin B12, and vitamin B6, which are essential for homocysteine remethylation.
Betaine (trimethylglycine) as an alternative methyl group donor.
Treatment of underlying conditions (e.g., kidney insufficiency, liver disease).
Dietary adjustments including foods rich in methyl-group nutrients (e.g., eggs, liver, legumes, leafy green vegetables).

References

Mato, J.M. et al. - S-Adenosylmethionine metabolism and liver disease. In: Annals of Hepatology, 2013.
Ueland, P.M. - Homocysteine species as components of plasma redox thiol status. In: Clinical Chemistry, 1995.
Fowler, B. - Homocysteine: overview of biochemistry, molecular biology, and role in disease processes. In: Seminars in Vascular Medicine, 2005.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.